MICRO LABS LTD FDA Approval ANDA 203080

ANDA 203080

MICRO LABS LTD

FDA Drug Application

Application #203080

Application Sponsors

ANDA 203080MICRO LABS LTD

Marketing Status

Prescription001

Application Products

001TABLET;ORAL200MG0NEVIRAPINENEVIRAPINE

FDA Submissions

UNKNOWN; ORIG1AP2012-05-22
LABELING; LabelingSUPPL2AP2020-07-21STANDARD
LABELING; LabelingSUPPL3AP2020-07-21STANDARD

Submissions Property Types

ORIG1Null15
SUPPL2Null7
SUPPL3Null7

TE Codes

001PrescriptionAB

CDER Filings

MICRO LABS LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 203080
            [companyName] => MICRO LABS LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"NEVIRAPINE","activeIngredients":"NEVIRAPINE","strength":"200MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"05\/22\/2012","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2012-05-22
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.